Globus Medical (GMED) Change in Accured Expenses (2011 - 2026)

Globus Medical's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$24.7 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 13.92% year-over-year to -$24.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.2 million (up 272.9% YoY) and the FY2025 annual result came in at $34.2 million, up 581.21% from the prior year.
• Change in Accured Expenses was -$24.7 million for Q1 2026 at Globus Medical, down from $8.8 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $39.3 million in Q3 2025 and bottomed at -$33.9 million in Q1 2024.
• A 5-year average of $2.2 million and a median of $4.9 million in 2024 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 234.24% in 2024, while the deepest fall reached 239.86% in 2024.
• Globus Medical's Change in Accured Expenses stood at $4.4 million in 2022, then tumbled by 177.98% to -$3.5 million in 2023, then surged by 234.24% to $4.6 million in 2024, then soared by 89.36% to $8.8 million in 2025, then slumped by 381.12% to -$24.7 million in 2026.
• Business Quant data shows GMED's Change in Accured Expenses at -$24.7 million in Q1 2026, $8.8 million in Q4 2025, and $39.3 million in Q3 2025.